Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin: A review of its potential functions and effects on neurological diseases
Mehmet Günata, Hakan Parlakpınar, Ahmet Acet
Revue Neurologique (2019) Vol. 176, Iss. 3, pp. 148-165
Closed Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders
Sheikh Bilal Ahmad, Aarif Ali, Midhat Bilal, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2437-2458
Open Access | Times Cited: 131
Understanding light pollution: Recent advances on its health threats and regulations
Miao Cao, Ting Xu, Daqiang Yin
Journal of Environmental Sciences (2022) Vol. 127, pp. 589-602
Closed Access | Times Cited: 73
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management
K. B. Megha, A. Arathi, Saini Shikha, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5541-5571
Closed Access | Times Cited: 19
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses
Masaru Tanaka, László Vécsei
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1083-1083
Open Access | Times Cited: 17
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Dongmei Chen, Tao Zhang, Tae Ho Lee
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 108
Study on metabolic variation in whole grains of four proso millet varieties reveals metabolites important for antioxidant properties and quality traits
Wei Li, Lichao Wen, Zhentian Chen, et al.
Food Chemistry (2021) Vol. 357, pp. 129791-129791
Closed Access | Times Cited: 96
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1569-1596
Open Access | Times Cited: 57
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
Dmytro I. Boiko, Anastasiia D. Shkodina, Mohammad Mehedi Hasan, et al.
Neurochemical Research (2022) Vol. 47, Iss. 10, pp. 2909-2924
Open Access | Times Cited: 43
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
Dongmei Chen, Guihua Lan, Ruomeng Li, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model
Marcos K. Andrade, Leonardo C. Souza, Evellyn M. Azevedo, et al.
IBRO Neuroscience Reports (2023) Vol. 14, pp. 264-272
Open Access | Times Cited: 26
A review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of the Astragalus memeranaceus
Panpan Wang, Zhen Wang, Zhanping Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
Jiao Tian, Xing-Qin Wang, Zhen Tian
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Melatonin exerts neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ‐induced diabetic mice
Hui Che, Hui Li, Yang Li, et al.
The FASEB Journal (2020) Vol. 34, Iss. 10, pp. 14042-14054
Closed Access | Times Cited: 47
Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health
Russel J. Reıter, Ramaswamy Sharma, Sergio Rosales‐Corral, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 605, pp. 70-81
Closed Access | Times Cited: 25
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging
Victoria Jiménez, Eva Ramos, Pedro Segura‐Chama, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1844-1844
Open Access | Times Cited: 14
Melatonin as a master regulatory hormone for genetic responses to biotic and abiotic stresses in model plant Arabidopsis thaliana: a comprehensive review
Muaz Ameen, Asma Zafar, Athar Mahmood, et al.
Functional Plant Biology (2024) Vol. 51, Iss. 2
Closed Access | Times Cited: 5
Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
Muhammad Shahid Nadeem, Salman Hosawi, Sultan Alshehri, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1635-1635
Open Access | Times Cited: 32
Progress in Research on the Effect of Melatonin on Postoperative Cognitive Dysfunction in Older Patients
Yuqing Wei, Chun‐Lu Zhang, Danyang Wang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 22
Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis
Begoña M. Escribano, Ana Muñoz-Jurado, Javier Caballero‐Villarraso, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103520-103520
Open Access | Times Cited: 21
Melatonin regulates microglial polarization to M2 cell via RhoA/ROCK signaling pathway in epilepsy
Pingping Li, Xuefei Ji, Ming Shan, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 11
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 6, pp. 3867-3895
Closed Access | Times Cited: 4
Effects of a nighttime melatonin ingestion on dynamic postural balance and muscle strength the following morning in people living with multiple sclerosis: A preliminary study
Sonda Jallouli, S. Ghroubi, Salma Sakka, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 238, pp. 108165-108165
Closed Access | Times Cited: 4
Melatonin as an add-on treatment for epilepsy: A systematic review and meta-analysis
Z X Liu, Jie Wei Zhu, Ziyi Shen, et al.
Seizure (2024) Vol. 117, pp. 133-141
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top